资讯
BlueStone Jewellery & Lifestyle shares debuted negatively at ₹510 on NSE, down 1.35% from its IPO price. The ₹1,540.65 crore ...
21 小时on MSN
Novo Nordisk slashes price of Ozempic in half to $499 for cash-paying, eligible U.S. patients
Novo Nordisk has announced a sweeping reduction in the cost of its blockbuster diabetes drug Ozempic, cutting the monthly ...
The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes ...
BlueStone Jewellery shares debuted with a slight discount, opening at Rs 510 on NSE and Rs 508.80 on BSE, against an IPO ...
Novo Nordisk is slashing the price of its blockbuster diabetes drug Ozempic for U.S. patients who self-pay or are uninsured.
Novo Nordisk announced Monday that US patients can now get a month’s supply of Ozempic, the blockbuster diabetes drug, for ...
BlueStone’s IPO comprised a fresh issue worth up to INR 1,000 Cr along with an OFS of up to 2.4 Cr shares by existing ...
Shares of Bluestone Jewellery listed at ₹508.80 on the BSE, down 1.59% from the IPO price of ₹517, with a market ...
51 分钟
Self Employed on MSNGold Prices Double Since 2022 as Kinross Gold Joins Stock Spotlight
The post Gold Prices Double Since 2022 as Kinross Gold Joins Stock Spotlight appeared first on Self Employed.
19 小时on MSN
Terry McLaurin seeks $33 million per year from Commanders to match DK Metcalf's price, per ...
The Washington Commanders activated wide receiver Terry McLaurin from the PUP list over the weekend and want him at practice ...
3 小时
Zacks Investment Research on MSNEarnings Growth & Price Strength Make Goldman Sachs (GS) a Stock to Watch
Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success. The Zacks Premium service ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果